Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 7
Submit an article Journal homepage
3,745
Views
48
CrossRef citations to date
0
Altmetric
Original Research

Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer

Guoying ZhouDepartments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsORCID Iconhttp://orcid.org/0000-0002-0108-2103 http://orcid.org/0000-0002-0108-2103 http://orcid.org/0000-0002-0108-2103View further author information
ORCID Icon ORCID Icon ORCID Icon,
Lisanne NoordamDepartments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsView further author information
,
Dave SprengersDepartments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsView further author information
,
Michail DoukasDepartment of Pathology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsORCID Iconhttp://orcid.org/0000-0002-8611-840XView further author information
ORCID Icon,
Patrick P. C. BoorDepartments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsView further author information
,
Adriaan A. van BeekDepartments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsORCID Iconhttp://orcid.org/0000-0003-0786-1682View further author information
ORCID Icon,
Remco ErkensDepartments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsORCID Iconhttp://orcid.org/0000-0002-3962-7228View further author information
ORCID Icon,
Shanta ManchamDepartments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsView further author information
,
Dirk GrünhagenDepartment of Surgery, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsORCID Iconhttp://orcid.org/0000-0001-8293-6002View further author information
ORCID Icon,
Anand G. MenonDepartment of Surgery, Havenziekenhuis and IJsselland Hospital, Rotterdam, the NetherlandsView further author information
,
Johan F. LangeDepartment of Surgery, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsView further author information
,
Pim J. W. A. BurgerDepartment of Surgery, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsView further author information
,
Alexandra BrandtDepartment of Surgery, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsView further author information
,
Boris GaljartDepartment of Surgery, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsView further author information
,
Cornelis VerhoefDepartment of Surgery, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsORCID Iconhttp://orcid.org/0000-0001-9980-8613View further author information
ORCID Icon,
Jaap KwekkeboomDepartments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsCorrespondence[email protected]
View further author information
&
Marco J. BrunoDepartments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsView further author information
 show all
Article: e1448332 | Received 15 Dec 2017, Accepted 28 Feb 2018, Published online: 25 Apr 2018

Citations (48)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Irma Herrera-Camacho, Maricruz Anaya-Ruiz, Martin Perez-Santos, Lourdes Millán-Pérez Peña, Cindy Bandala & Gerardo Landeta. (2019) Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1. Expert Opinion on Therapeutic Patents 29:8, pages 587-593.
Read now

Articles from other publishers (47)

Farangis Rastin, Hossein Javid, Mahsa Akbari Oryani, Nastaran Rezagholinejad, Amir-R. Afshari & Mehdi Karimi-Shahri. (2024) Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress. International Immunopharmacology 126, pages 111055.
Crossref
Jia-Jun Li, Jin-Hong Wang, Tian Tian, Jia Liu, Yong-Qiang Zheng, Hai-Yu Mo, Hui Sheng, Yan-Xing Chen, Qi-Nian Wu, Yi Han, Kun Liao, Yi-Qian Pan, Zhao-Lei Zeng, Ze-Xian Liu, Wei Yang, Rui-Hua Xu & Huai-Qiang Ju. (2023) The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer. Nature Communications 14:1.
Crossref
Allison L. Balasko, Monika M. Kowatsch, Colin Graydon, Julie Lajoie & Keith R. Fowke. (2023) The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function. Scientific Reports 13:1.
Crossref
Xiaomei Zhuang, Gang Deng, Xiaoying Wu, Juping Xie, Dong Li, Songlin Peng, Di Tang & Guoying Zhou. (2023) Recent advances of three-dimensional bioprinting technology in hepato-pancreato-biliary cancer models. Frontiers in Oncology 13.
Crossref
Hanju Hua, Wenguang He, Nan Chen, Yinjun He, Guosheng Wu, Feng Ye, Xile Zhou, Yandong Li, Yongfeng Ding, Weixiang Zhong, Lisong Teng, Weiqin Jiang & Qinsong Sheng. (2023) Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy. Frontiers in Immunology 13.
Crossref
Yiming Ma, Lei Zhan, Jun Yang & Jingdong Zhang. (2022) SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer. Frontiers in Pharmacology 13.
Crossref
Swati Sonal, Vikram Deshpande, David T. Ting, James C. Cusack, Aparna R. Parikh, Azfar Neyaz, Amaya Pankaj, Martin S. Taylor, Anne M. Dinaux, Lieve G. J. Leijssen, Chloe Boudreau, Joseph J. Locascio, Hiroko Kunitake, Robert N. Goldstone, Liliana G. Bordeianou, Christy E. Cauley, Rocco Ricciardi & David L. Berger. (2022) Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma. Annals of Surgical Oncology 29:12, pages 7372-7382.
Crossref
Osman Yılmaz, Amaya Pankaj, Azfar Neyez, Steffen Rickelt, Martin Taylor, Evan R. Lang, Lieve Leijsen, Anne Dinaux, Stuti G. Shroff, Rory Crotty, M. Lisa Zhang, Sandra Cerda, Qing Zhao, Cristina Ferrone, David T. Ting, Deepa T. Patil, Omer Yilmaz, David Berger & Vikram Deshpande. (2022) Programmed death-ligand 1 expression in the immune compartment of colon carcinoma. Modern Pathology 35:11, pages 1740-1748.
Crossref
Jakub Litak, Wojciech Czyżewski, Michał Szymoniuk, Leon Sakwa, Barbara Pasierb, Joanna Litak, Zofia Hoffman, Piotr Kamieniak & Jacek Roliński. (2022) Biological and Clinical Aspects of Metastatic Spinal Tumors. Cancers 14:19, pages 4599.
Crossref
Natalia Sauer, Wojciech Szlasa, Laura Jonderko, Małgorzata Oślizło, Dominika Kunachowicz, Julita Kulbacka & Katarzyna Karłowicz-Bodalska. (2022) LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors. International Journal of Molecular Sciences 23:17, pages 9958.
Crossref
Yao Chen, Bingjun Bai, Kangkang Ying, Hongming Pan & Binbin Xie. (2022) Anti-PD-1 combined with targeted therapy: Theory and practice in gastric and colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:5, pages 188775.
Crossref
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, Fariba Karoon Kiani, Mohammad Mohammadi, Negin Afsharimanesh, Farbod Ebrahimi, Seyed Hossein Kiaie, Jamshid Gholizadeh Navashenaq, Mohammad Hojjat-Farsangi, Naime Majidi Zolbanin, Ata Mahmoodpoor, Hadi Hassannia, Sanam Nami, Pooya Jalali, Reza Jafari & Farhad Jadidi-Niaragh. (2022) Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model. Pharmaceutical Research 39:8, pages 1851-1866.
Crossref
Alhasan Alsalman, Mohammad A. Al-Mterin, Khaled Murshed, Ferial Alloush, Samia T. Al-Shouli, Salman M. Toor & Eyad Elkord. (2022) Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients. Cancers 14:13, pages 3194.
Crossref
Yufang Hou, Rixin Zhang, Jinbao Zong, Weiqi Wang, Mingxuan Zhou, Zheng Yan, Tiegang Li, Wenqiang Gan, Silin Lv, Zifan Zeng & Min Yang. (2022) Comprehensive Analysis of a Cancer-Immunity Cycle–Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer. Frontiers in Immunology 13.
Crossref
Lishu ZhaoHao WangKandi XuXinyue LiuYayi He. (2022) Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications. Chinese Medical Journal 135:10, pages 1203-1212.
Crossref
Guanglin Cui. (2022) Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives. Biomedicine & Pharmacotherapy 149, pages 112923.
Crossref
Hui Zhou, Zhongtao Liu, Yongxiang Wang, Xiaoyong Wen, Eric H. Amador, Liqin Yuan, Xin Ran, Li Xiong, Yuping Ran, Wei Chen & Yu Wen. (2022) Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal Transduction and Targeted Therapy 7:1.
Crossref
Cong Zhou, Xiaojiao Cheng & Shuiping Tu. (2021) Current status and future perspective of immune checkpoint inhibitors in colorectal cancer. Cancer Letters 521, pages 119-129.
Crossref
Cameron J. Herting, Matthew R. Farren, Yan Tong, Ziyue Liu, Bert O’Neil, Tanios Bekaii-Saab, Anne Noonan, Christopher McQuinn, Thomas A. Mace, Walid Shaib, Christina Wu, Bassel F. El-Rayes, Safi Shahda & Gregory B. Lesinski. (2021) A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186. Cancer Immunology, Immunotherapy 70:11, pages 3337-3348.
Crossref
Yuanming Xu, Lucia Campos Carrascosa, Yik Andy Yeung, Matthew Ling-Hon Chu, Wenjing Yang, Ivana Djuretic, Danielle C. Pappas, John Zeytounian, Zhouhong Ge, Valeska de Ruiter, Gabriel R. Starbeck-Miller, James Patterson, Diamanda Rigas, Shih-Hsun Chen, Eugenia Kraynov, Patrick P. Boor, Lisanne Noordam, Michael Doukas, Dave Tsao, Jan N. Ijzermans, Jie Guo, Dirk J. Grünhagen, Joris Erdmann, Joanne Verheij, Martin E. van Royen, Pascal G. Doornebosch, Renny Feldman, Terrence Park, Salah Mahmoudi, Magdalena Dorywalska, Irene Ni, Sherman M. Chin, Tina Mistry, Lidia Mosyak, Laura Lin, Keith A. Ching, Kevin C. Lindquist, Changhua Ji, Luz Marina Londono, Bing Kuang, Robert Rickert, Jaap Kwekkeboom, Dave Sprengers, Tzu-Hsuan Huang & Javier Chaparro-Riggers. (2021) An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity. Cancer Immunology Research 9:10, pages 1141-1157.
Crossref
Shima Makaremi, Zahra Asadzadeh, Nima Hemmat, Amir Baghbanzadeh, Alessandro Sgambato, Farid Ghorbaninezhad, Hossein Safarpour, Antonella Argentiero, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris & Behzad Baradaran. (2021) Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects. Biomedicines 9:9, pages 1075.
Crossref
Worawat Songjang, Chatchai Nensat, Sutatip Pongcharoen & Arunya Jiraviriyakul. (2021) The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review). Biomedical Reports 15:4.
Crossref
Yingru Zhang, Yiyang Zhao, Qi Li & Yan Wang. (2021) Macrophages, as a Promising Strategy to Targeted Treatment for Colorectal Cancer Metastasis in Tumor Immune Microenvironment. Frontiers in Immunology 12.
Crossref
Saber Mehdizadeh, Hashem Bayatipoor, Salar Pashangzadeh, Roghayeh Jafarpour, Zeinab Shojaei & Morteza Motallebnezhad. (2021) Immune checkpoints and cancer development: Therapeutic implications and future directions. Pathology - Research and Practice 223, pages 153485.
Crossref
Xiao-Juan Chen, Aiqun Ren, Liang Zheng, En-Dian Zheng & Tao Jiang. (2021) Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome. Frontiers in Immunology 12.
Crossref
Preeti Kanikarla Marie, Cara Haymaker, Edwin Roger Parra, Young Uk Kim, Rossana Lazcano, Swati Gite, Daniele Lorenzini, Ignacio I. Wistuba, Rebecca S. Slack Tidwell, Xiaofei Song, Wai Chin Foo, Dipen M. Maru, Yun Shin Chun, Andy Futreal, Bryan Kee, David Menter, Luisa Solis, Ching-Wei Tzeng, Christine Parseghian, Kanwal Raghav, Van Morris, Chia-Chi Chang, Robert Jenq, Alda Tam, Chantale Bernatchez, Scott Kopetz, Jean-Nicolas Vauthey & Michael J. Overman. (2021) Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases. Clinical Cancer Research 27:11, pages 3039-3049.
Crossref
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. González-Rodríguez, Ángel R. Payer, Esther González-García, Alejandro López-Soto & Segundo Gonzalez. (2021) LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia. Cancers 13:9, pages 2112.
Crossref
Jun-Zhen Fan, Gao-Fei Wang, Xue-Bin Cheng, Zhou-Huan Dong, Xin Chen, Yu-Jiao Deng & Xin Song. (2021) Relationship between mismatch repair protein, RAS , BRAF , PIK3CA gene expression and clinicopathological characteristics in elderly colorectal cancer patients . World Journal of Clinical Cases 9:11, pages 2458-2468.
Crossref
Matthew Alderdice, Stephanie G Craig, Matthew P Humphries, Alan Gilmore, Nicole Johnston, Victoria Bingham, Vicky Coyle, Seedevi Senevirathne, Daniel B Longley, Maurice B Loughrey, Stephen McQuaid, Jacqueline A James, Manuel Salto-Tellez, Mark Lawler & Darragh G McArt. (2021) Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer . NAR Genomics and Bioinformatics 3:2.
Crossref
Dongdong Ti, Miaomiao Bai, Xiaolei Li, Jianshu Wei, Deyun Chen, Zhiqiang Wu, Yao Wang & Weidong Han. (2020) Adaptive T cell immunotherapy in cancer. Science China Life Sciences 64:3, pages 363-371.
Crossref
Sarah C. Edwards, Wilma H. M. Hoevenaar & Seth B. Coffelt. (2020) Emerging immunotherapies for metastasis. British Journal of Cancer 124:1, pages 37-48.
Crossref
Fabien Franco, Alison Jaccard, Pedro Romero, Yi-Ru Yu & Ping-Chih Ho. (2020) Metabolic and epigenetic regulation of T-cell exhaustion. Nature Metabolism 2:10, pages 1001-1012.
Crossref
Jonadab E. Olguín, Itzel Medina-Andrade, Tonathiu Rodríguez, Miriam Rodríguez-Sosa & Luis I. Terrazas. (2020) Relevance of Regulatory T Cells during Colorectal Cancer Development. Cancers 12:7, pages 1888.
Crossref
Diederik J. Höppener, Pieter M. H. Nierop, Joost Hof, Kostandinos Sideras, Guoying Zhou, Lydia Visser, Annette S. H. Gouw, Koert P. de Jong, Dave Sprengers, Jaap Kwekkeboom, Peter B. Vermeulen, Dirk J. Grünhagen & Cornelis Verhoef. (2020) Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis. British Journal of Cancer 123:2, pages 196-206.
Crossref
Mara Kitsou, Georgios Ayiomamitis & Apostolos Zaravinos. (2020) High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer. International Journal of Oncology.
Crossref
Lu Wang, Yinan Sun, Minxiao Yi, Weiheng Zhao & Xianglin Yuan. (2020) IEO model: A novel concept describing the complete metastatic process in the liver microenvironment (Review). Oncology Letters.
Crossref
Ssu-Hsueh Tseng, Sung-Taek Park, Brandon Lam, Ya-Chea Tsai, Max A Cheng, Emily Farmer, Deyin Xing & Chien-Fu Hung. (2020) Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis. Journal for ImmunoTherapy of Cancer 8:1, pages e000480.
Crossref
Lisa J. Henderson, Lauren B. Reoma, Joseph A. Kovacs & Avindra Nath. (2020) Advances toward Curing HIV-1 Infection in Tissue Reservoirs. Journal of Virology 94:3.
Crossref
Anita Sveen, Scott Kopetz & Ragnhild A. Lothe. (2019) Biomarker-guided therapy for colorectal cancer: strength in complexity. Nature Reviews Clinical Oncology 17:1, pages 11-32.
Crossref
Huimin Du, Ziying Yi, Long Wang, Zhi Li, Bailin Niu & Guosheng Ren. (2020) The co-expression characteristics of LAG3 and PD-1 on the T cells of patients with breast cancer reveal a new therapeutic strategy. International Immunopharmacology 78, pages 106113.
Crossref
Guoying Zhou, Dave Sprengers, Shanta Mancham, Remco Erkens, Patrick P.C. Boor, Adriaan A. van Beek, Michail Doukas, Lisanne Noordam, Lucia Campos Carrascosa, Valeska de Ruiter, Roelof W.F. van Leeuwen, Wojciech G. Polak, Jeroen de Jonge, Bas Groot Koerkamp, Belle van Rosmalen, Thomas M. van Gulik, Joanne Verheij, Jan N.M. IJzermans, Marco J. Bruno & Jaap Kwekkeboom. (2019) Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules. Journal of Hepatology 71:4, pages 753-762.
Crossref
Jooeun Bae, Mehmet Samur, Paul Richardson, Nikhil C. Munshi & Kenneth C. Anderson. (2019) Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy. Leukemia 33:9, pages 2208-2226.
Crossref
Hsing-Ju Wu & Pei-Yi Chu. (2019) Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. International Journal of Molecular Sciences 20:17, pages 4154.
Crossref
Bailin Niu, Fachun Zhou, Yanxin Su, Long Wang, Yuanyuan Xu, Ziying Yi, Yushen Wu, Huimin Du & Guosheng Ren. (2019) Different Expression Characteristics of LAG3 and PD-1 in Sepsis and Their Synergistic Effect on T Cell Exhaustion: A New Strategy for Immune Checkpoint Blockade. Frontiers in Immunology 10.
Crossref
Hyung-Don Kim & Su-Hyung Park. (2019) Immunological and clinical implications of immune checkpoint blockade in human cancer. Archives of Pharmacal Research 42:7, pages 567-581.
Crossref
Hanju Hua, Wenguang He, Nan Chen, Yinjun He, Guosheng Wu, Feng Ye, Xile Zhou, Yandong Li, Yongfeng Ding, Weixiang Zhong, Lisong Teng, Weiqin Jiang & Qinsong Sheng. (2022) Genomic and Transcriptomic Analysis of Microsatellite Instability-High Colorectal Cancer Patients with Targetable Alterations Identifies Clinical Implications for Immunotherapy. SSRN Electronic Journal.
Crossref
Asal Barshidi, vahid karpisheh, Fatemeh Karimian Noukabadi, Fariba Karoon Kiani, Negin Afsharimanesh, Farbod Ebrahimi, Seyed Hossein Kiaie, Pooya Jalali, Mohammad Hojjat-Farsangi, Naime Majidi Zolbanin, Ata Mahmoodpoor, hadi Hassannia, Sanam Nami, Reza Jafari & Farhad Jadidi-Niaragh. (2021) Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.